Introduction {#sec1}
============

Benzofuran is an important fused oxygen heterocycle found in both natural products and many synthetic products used in drugs, polymers, and agrochemicals.^[@ref1]^ Substituted benzofurans exhibit numerous medicinal properties such as antifungal,^[@ref2]^ antitumour,^[@ref3]^ anti-inflammatory,^[@ref4]^ antiviral,^[@ref5]^ and antineoplastic activities.^[@ref6]^ Considering diverse applications of benzofuran derivatives, the design and development of novel methods for their synthesis has remained an important topic in organic synthesis.^[@ref7]^ Benzofuran derivatives such as 3-amino-2-aroyl benzofurans have diverse pharmaceutical applications. For example, compound **A** is an anticonvulsant and neurotoxic compound^[@ref8]^ and compound **B** showed inhibition in tubulin polymerization ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref9]^ Similarly, compound **C** is a potent and selective P2X4 receptor antagonist, which can be easily prepared from 3-amino-2-aroyl benzofuran derivatives.^[@ref10]^

![Representative examples of bioactive 3-amino-2-acyl benzofuran derivatives.](ao9b04169_0018){#fig1}

In addition to these applications, 3-amino-2-aroyl benzofurans are used as starting materials for the preparation of diverse benzofuran-fused heterocycles having significant medicinal or optoelectronic properties. Recently, 3-amino-2-aroyl benzofuran has been used as a starting material under different reaction conditions for the preparation of benzofuran-fused quinolines^[@ref11]^ and pyridines,^[@ref12]^ as shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. The synthesis of 3-amino-2-aroyl benzofuran derivatives was first reported by Gewald et al. using in situ NaOEt.^[@ref13]^ Later, modified methods were developed using various base and solvent systems. Habermann et al. reported an alternative method using a polymer-supported base TBD-P (1,5,7-triazabicyclo\[4.4.0\]dec-5-ene) in acetone medium under reflux conditions.^[@ref14]^

![Reported Methods for the Synthesis of Benzofuran-Fused Heterocycles Using 3-Amino-2-Aroyl Benzofuran as a Starting Material](ao9b04169_0001){#sch1}

K~2~CO~3~-mediated two-component reactions in acetone medium under reflux conditions with long reaction time (12 h) are also known.^[@ref15]^ It is noteworthy to mention that most of the reported methods suffer from one or the other limitations such as long reaction time, a two-step process with the involvement of two bases, harsh reaction conditions, and relatively low yields. Considering the significance of 3-amino-2-aroyl benzofuran and its derivatives in both medicinal and organic chemistry, we realized the scope to develop an efficient, straightforward method for the one-step preparation of these molecules in good to excellent yields in a shorter time and at ambient temperature. Cs~2~CO~3~ is a versatile reagent in organic synthesis.^[@ref16]^ Apart from its basicity, it also acts as a source of carbon in many organic transformations.^[@ref17]^ Unlike other metal carbonates, Cs~2~CO~3~ shows exceptional reactivity in polar aprotic solvents such as dimethylformamide (DMF) due to its high solubility and the lowest degree of solvation and ion pairing than the ions of analogous alkali-metal salts. Considering these, most often, this reagent shows better results, which is also known as the "cesium effect".^[@ref18]^ Recently, Cs~2~CO~3~ has been used in various organic reactions involving C--C, C--N, C--O, and C--S bond formation.^[@ref19]^ In view of its virtues, we were motivated to explore this reagent for our methodology for the synthesis of 3-aminobenzofuran derivatives.

In addition to 3-aminobenzofurans, their *N*-arylated derivatives also exhibit diverse medicinal properties.^[@ref20]^ Conventionally, *N*-arylation of amines is performed using aryl halide in the presence of either Pd or Cu catalysts at high temperature.^[@ref21]^ Chan--Lam coupling using arylboronic acid is an alternative approach for the C--N bond formation at relatively lower temperature.^[@ref22]^ To the best of our knowledge, there is no report in the literature for the preparation of 3-arylamino-2-aroyl benzofuran derivatives using the Chan--Lam coupling reaction. Recently, Romagnoli et al. prepared novel 3-arylaminobenzofuran derivatives by a two-step reaction involving aryl iodides using Pd(OAc)~2~, BINAP, and Cs~2~CO~3~, in a toluene medium at 100 °C for the C--N bond-forming step.^[@ref20]^ Similarly, Wang et al. reported a Pd-catalyzed one-pot three-component reaction involving isonitriles, 2-iodophenols, and 2-bromoacetophenones for the synthesis of 3-aminoalkyl/aryl-2-benzoyl benzofurans.^[@ref23]^ In continuation of our quest for developing new and improved methodologies, we wanted to prepare *N*-arylated derivatives of our 3-aminobenzofuran derivatives by an alternative and efficient method using a readily available cheaper catalyst and at ambient temperature. Copper salts are relatively cheaper and readily available catalysts for the *N*-arylation reactions using either aryl halides or arylboronic acids.^[@ref24]^ Recently, we have developed a CuCl~2~-catalyzed domino reaction in DMF medium for the one-pot synthesis of pyrimidine-fused quinolines.^[@ref25]^ In continuation of our work on the development of novel methodologies, herein, we report a Cs~2~CO~3~-mediated highly efficient methodology for the preparation of 3-amino-2-aroyl benzofuran derivatives from the readily available starting materials at room temperature (rt). We also report a base- and ligand-free copper-catalyzed room-temperature C--N bond-forming methodology for the easy access of mono- and bi-*N*-arylated aminobenzofuran derivatives using arylboronic acids. Finally, our two-component benzofuran derivatives were further explored for the synthesis of a highly fluorescent novel alkene and a benzofuran-fused pyridine in the presence of Cs~2~CO~3~ as a base under microwave heating conditions, as shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}.

![This Work](ao9b04169_0012){#sch2}

Results and Discussion {#sec2}
======================

In continuation of our work on the synthesis of fused heterocycles, initially, we tried to prepare the benzofuran derivative **3a** from the reaction of 2-hydroxybenzonitrile (**1a**) and 2-bromoacetophenone (**2a**) in DMF medium in the presence of Cs~2~CO~3~ (1.0 equiv) as a base. Within 12 h of room-temperature stirring, this reaction provided our desired benzofuran derivative **3a** in a good yield. Compound **3a** was fully characterized by ^1^H and ^13^C NMR spectroscopies as well as by recording high-resolution mass spectrometry (HRMS). Interestingly, by increasing the amount of Cs~2~CO~3~ to 2.0 equiv, we observed a drastic change in the rate of the reaction; the reaction completed within 10 min, and the corresponding desired benzofuran derivative **3a** was obtained in 92% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 2). This exciting result prompted us to investigate the effect of other metal carbonates as well as the screening of solvents in this reaction.

###### Optimization of the Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao9b04169_0010){#fx1}

  entry   solvent   base (*x* equiv)                    reaction conditions   reaction time   yield (%)[b](#t1fn2){ref-type="table-fn"}   ratio[c](#t1fn3){ref-type="table-fn"}**3a:3a′**
  ------- --------- ----------------------------------- --------------------- --------------- ------------------------------------------- -------------------------------------------------
  1       DMF       Cs~2~CO~3~ (1)                      rt                    12 h            85                                          1:0
  **2**   **DMF**   **Cs**~**2**~**CO**~**3**~**(2)**   **rt**                **10 min**      **92**                                      **1:0**
  3       DMF       Na~2~CO~3~ (2)                      rt                    2 h             92                                          1:1.4
  4       DMF       K~2~CO~3~ (2)                       rt                    2 h             82                                          1:1
  5       DMF       K~2~CO~3~ (2)                       100 °C                2 h             86                                          1:0
  6       DMF       Et~3~N (2)                          rt                    1 h             76                                          1:9
  7       DMF       Cs~2~CO~3~ (1)                      rt                    10 min          92                                          0:1
  8       DMSO      Cs~2~CO~3~ (2)                      rt                    30 min          88                                          7:3
  9       MeOH      Cs~2~CO~3~ (2)                      reflux                10 h            85                                          0:1
  10      Me~2~CO   Cs~2~CO~3~ (2)                      reflux                10 h            90                                          1:0
  11      THF       Cs~2~CO~3~ (2)                      reflux                10 h            82                                          1:0
  12      H~2~O     Cs~2~CO~3~ (2)                      reflux                10 h            75                                          0:1

Reaction conditions: **1a** (0.5 mmol), **2a** (0.5 mmol), and the solvent (2.0 mL) stirred at the indicated time and temperature.

Isolated yield.

The ratio was determined from the ^1^H NMR spectra of crude product(s).

Using 2.0 equiv of Na~2~CO~3~ in place of cesium carbonate and keeping DMF as a solvent, the same reaction provided a mixture of two products **3a** and **3a′** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3). Likewise, using K~2~CO~3~ (2.0 equiv) in DMF medium, a mixture of products **3a** and **3a′** was obtained from the room-temperature reaction even after 2 h stirring ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). However, performing this reaction at 100 °C in the presence of K~2~CO~3~ in DMF medium provided only our desired cyclic product **3a**. We also screened the organic base Et~3~N for this model reaction at room temperature. Interestingly, even after 1 h, we observed acyclic intermediate **3a′** as the major product for this reaction. It is noteworthy to mention that in this reaction, the stoichiometry of a base is very important for the efficient synthesis of our desired benzofurans. For example, the reaction in the presence of 1.0 equiv Cs~2~CO~3~ in DMF medium provided us exclusively acyclic intermediate **3a′** within 10 min ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 7). For the efficient conversion, 2.0 equiv of Cs~2~CO~3~ is required for this transformation. After having these results, we also wanted to find the best solvent for this reaction. Different solvents such as dimethyl sulfoxide (DMSO), MeOH, Me~2~CO, tetrahydrofuran (THF), and H~2~O were screened using 2.0 equiv of a base. Protic solvents such as methanol and water provided only acyclic product **3a′** even after long reaction time under refluxed conditions. On the other hand, aprotic polar solvents such as acetone and THF provided our desired product **3a** using Cs~2~CO~3~ as a base under reflux conditions. From this optimization table, it is evident that 2.0 equiv of Cs~2~CO~3~ in DMF medium provided the best result in the shortest time. Thus, 2.0 equiv Cs~2~CO~3~ in 2.0 mL DMF at room temperature was considered as the optimum reaction condition.

After having this optimized reaction condition, next, we explored the substrate scope and generality of this method by varying 2-hydroxybenzonitriles and 2-bromoacetophenones. A wide variety of 2-bromoacetophenone derivatives having −CH~3~, −OCH~3~, −CN, −NO~2~, −F, −Cl, and −Br at different positions of the aryl ring were tested, and corresponding 3-amino-2-aroylbezofurans were obtained in good to very good yields.

Similarly, the variability of 2-hydroxybenzonitrile derivatives was also checked using 2-bromoacetophenone derivatives having −F and −Br substituents and, in these cases, also corresponding products were obtained in good yields, and the results are summarized in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. All of the products were fully characterized using IR, ^1^H, and ^13^C NMR spectroscopies as well as by HRMS.

###### Substrate Scope for the Synthesis of 3-Amino-2-Aroyl Benzofuran Derivatives[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}

![](ao9b04169_0006){#fx2}

Reaction conditions: **1a** (0.5 mmol), **2a** (0.5 mmol), Cs~2~CO~3~ (2.0 equiv), and DMF (2.0 mL) stirred at room temperature for 10--20 min.

Isolated yield.

We also tried this methodology at a 5.0 mmol scale to check the feasibility of gram-scale synthesis of 3-amino-2-aroyl benzofuran derivatives. Compounds **3a**, **3d**, and **3g** were synthesized in a 5.0 mmol scale reaction, and in all of these reactions, good to very good yields were observed ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Gram-Scale Synthesis of 3-Amino-2-Aroyl Benzofuran Derivatives](ao9b04169_0002){#sch3}

After developing this Cs~2~CO~3~-mediated efficient methodology for the preparation of 3-amino-2-aroyl benzofurans, next, we aimed to explore these products for the preparation of *N*-aryl derivatives. In continuation of our work on C--N bond-forming reactions, initially, we tried the reaction of **3a** and phenylboronic acid (**4a**). This two-component reaction in the absence of any catalysts in DMF medium provided only a trace amount of the mono-*N*-arylated product **5a** ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 1). Next, the same model reaction was tried in the presence of 10 mol % Cu(OAc)~2~, keeping the same solvent DMF as the reaction medium at room temperature. Within 12 h, our desired mono-*N*-arylated product **5a** was observed as the major product (45% yield) along with 5% bi-*N*-arylated product **6a** ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 2). Next, we performed the same reaction for a longer time (24 h) in DMF medium at room temperature. In this case, we observed better results in terms of the yield obtained ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 3). Interestingly, by increasing the catalyst loading up to 1.0 equiv and **4a** (1.2 equiv) within 8 h, corresponding mono- and bi-*N*-arylated products were obtained in good yields ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 4). Both these products were fully characterized by ^1^H and ^13^C NMR spectroscopies as well as by HRMS. Interestingly, when this model reaction was tried at room temperature in the presence of 10 mol % Cu(OAc)~2~ in methanol as a medium, a better and selective result (65% yield) for the desired mono-*N*-arylated product **5a** was observed ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 5).

###### Screening of the Reaction Conditions[a](#t3fn1){ref-type="table-fn"}
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                                                                                yield (%)[b](#t3fn2){ref-type="table-fn"}   
  -------- ---------------------------------- ---------- ---------- ----------- ------------------------------------------- -----------
  1                                           20 h       DMF        1:1         trace                                        
  2        Cu(OAc)~2~ (10 mol %)              12 h       DMF        1:1         45                                          5
  3        Cu(OAc)~2~ (10 mol %)              24 h       DMF        1:1         61                                          10
  4        Cu(OAc)~2~ (100 mol %)             8 h        DMF        1:1.2       72                                          6
  5        Cu(OAc)~2~ (10 mol %)              10 h       MeOH       1:1         65                                          trace
  6        Cu(OAc)~2~ (10 mol %)              12 h       MeOH       1:1.2       69                                          5
  **7**    **Cu(OAc)**~**2**~**(10 mol %)**   **8 h**    **DCM**    **1:1.2**   **73**                                      **trace**
  8        Cu(OAc)~2~ (15 mol %)              14 h       MeOH       1:1.5       30                                          35
  9        Cu(OAc)~2~ (20 mol %)              15 h       MeOH       1:2         20                                          50
  **10**   **Cu(OAc)**~**2**~**(20 mol %)**   **15 h**   **MeOH**   **1:2.5**   **5**                                       **66**

Reaction conditions: Reactions were performed on a 0.5 mmol scale of **3a**.

Isolated yield.

Next, we increased the amount of phenylboronic acid to 1.2 equiv, keeping all other reaction parameters the same in methanol medium. Under this condition, an improved yield (71%) of the desired mono-*N*-arylated product **5a** was observed along with 5% of the bi-*N*-arylated product **6a**. It is noteworthy to mention that replacing methanol with dichloromethane as the reaction medium and keeping phenylboronic acid as 1.2 equiv provided the best yield in the shortest time ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 7). Among all of the screened solvents, dichloromethane was found as the best solvent for the mono-*N*-arylation reaction of **3a**.

After having this successful result, we also wanted to find an optimum reaction condition for the preparation of the bi-*N*-arylated product by varying the amount of the catalyst, solvent, and phenylboronic acid. The reaction of **3a** with phenylboronic acid (1.5 equiv) in the presence of 15 mol % Cu(OAc)~2~ in methanol medium within 14 h with room-temperature stirring provided a higher amount of the bi-*N*-arylated product (**6a**, 35%) along with 30% of **5a** ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 8). Finally, the optimum condition for the bi-*N*-arylation was observed in the presence of 2.5 equiv of phenylboronic acid and 20 mol % Cu(OAc)~2~ in methanol medium at room-temperature stirring for 15 h ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 10). From this optimization table, we realized that 1.2 equiv of arylboronic acid in the presence of 10 mol % Cu(OAc)~2~ in dichloromethane as the solvent at room-temperature stirring under open flask conditions for 8--10 h gives the maximum yield of the mono-*N-*arylated benzofuran derivative, and for the *N*,*N*-biarylated product, the optimum yield was obtained using 2.5 equiv of arylboronic acid, 20 mol % of the catalyst, and a longer reaction time (15 h) in methanol medium.

Next, using our optimized reaction conditions, the scope of mono-*N*-arylation of aminobenzofurans was checked, and the results are summarized in [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}. Initially, **3a** was reacted with various phenylboronic acids having electron-donating groups such as 4-Me, 4-*^t^*Bu, and 4-OMe and the corresponding mono-*N*-arylated products **5b**--**d** were obtained in good yields. Similarly, bulky naphthylboronic acid was also found suitable for the reaction.

###### Substrate Scope for the Mono-*N*-Arylation of Aminobenzofurans[a](#t4fn1){ref-type="table-fn"}

![](ao9b04169_0014){#fx4}

Conditions: **1** (0.5 mmol.), **2** (0.6 mmol), Cu(OAc)~2~ (10 mol %) in dichloromethane (DCM) (2.0 mL), room temperature, air, 6--10 h.

Interestingly, 4-bromo phenylboronic acid having two reactive sites for C--N bond formation on reaction with **3a** under the optimized reaction conditions provided selectively the desired product **5f** in good yield. Under similar reaction conditions, the reaction of **3a** with arylboronic acid having electron-withdrawing groups such as 4-CF~3~ provided the corresponding mono-*N*-arylated product **5g** relatively in less yield (69%) and took a longer reaction time.

We also observed that ortho-disubstituted phenylboronic acid like 2-fluoro-6-iodophenyl boronic acid is not suitable to react with 3-amino-2-benzoyl benzofuran under the optimized reaction conditions to provide our expected product **5h**, which may be due to the electron-withdrawing nature of both −F and −I substituents as well as steric reasons. Next, to check the variability of 3-amino-2-aroyl benzofurans, various aminobenzofuran derivatives were reacted with phenylboronic acid and corresponding mono-*N*-arylated products **5i**--**l** were prepared in good yields. It is noteworthy to mention that only under the given reaction conditions, C--N bond formation products (**5k** and **5l**) were observed from the aminobenzofuran derivatives having bromo substituents and we did not observe any Suzuki-type coupling products. All of the products were fully characterized by recording melting points, ^1^H and ^13^C NMR spectroscopies, and HRMS. In addition, to confirm the structure of these products unambiguously, we recorded a single-crystal X-ray diffraction (XRD) of **5j**, shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}.

![Single-Crystal XRD of **5j** (CCDC 1958974).](ao9b04169_0016){#fig2}

We also checked the chemoselectivity of the reaction of **3g** and **4a** in the presence of copper and palladium catalysts. Using our standard copper-catalyzed method, we observed the corresponding mono-*N*-arylated product **5k**. On the other hand, in the presence of a catalytic amount of palladium acetate and potassium carbonate as a base in methanol medium under reflux conditions, the reaction of **3g** and **4a** provided the Suzuki coupling product **7a** instead of mono-*N*-arylation ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Chemoselective Arylation of **3g** in the Presence of Copper and Palladium Catalysts](ao9b04169_0003){#sch4}

After preparing these mono-*N*-arylated derivatives, next, we focused our attention on the preparation of *N*,*N*-biarylated derivatives using 2.5 equiv of arylboronic acids and 20 mol % of the copper catalyst in methanol medium. Using this biarylation strategy, we synthesized compounds **6a**, **6c**, **6d**, and **6i** by varying boronic acid derivatives as well as the 3-amino-2-aroyl benzofurans, and the results are summarized in [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}.

###### Substrate Scope for the Copper-Catalyzed Synthesis of *N*,*N*-Biaryl Derivatives of 3-Amino-2-Aroyl Benzofurans[a](#t5fn1){ref-type="table-fn"}^,^[b](#t5fn2){ref-type="table-fn"}
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Reaction conditions: **3** (0.5 mmol) and **4** (1.25 mmol) in 3.0 mL of MeOH at room-temperature stirring for 14--15 h.

Isolated yield.

We also tried to prepare mono-*N*-arylated aminobenzofuran **5a** from the one-pot three-component reaction. For this, a mixture of 2-hydroxybenzonitrile (1.0 mmol), 2-bromoacetophenone (1.0 mmol), and phenylboronic acid (1.2 mmol) was transferred to a 25.0 mL round-bottom flask. To this mixture, 2.0 equiv of Cs~2~CO~3~ and 1.0 equiv of Cu(OAc)~2~ were added and stirred at room temperature. Within 8 h, corresponding products **5a** (69%) along with 5% **6a** were observed ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).

![One-Pot Three-Component Synthesis of **5a** and **6a** in DMF Medium](ao9b04169_0013){#sch5}

After having these successful results, we turned our attention to utilize our 3-amino-2-aroyl benzofurans for the preparation of highly conjugated alkenes **8a** and **8c** by reaction with malononitrile ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). For this, initially, compound **3a** was prepared from the reaction of **1a** and **2a** using our standard reaction conditions in DMF medium at room temperature. Microwave heating is an efficient strategy for organic synthesis as well as for the drug discovery process.^[@ref26]^ Thus, we turned our attention to use this technique for the condensation reaction of **3a** and malononitrile. A mixture of malononitrile (1.5 equiv) and 1.0 equiv of Cs~2~CO~3~ was added to the in situ generated **3a** in DMF, and the resultant mixture was heated using a microwave reactor under sealed conditions for 30 min keeping the temperature at 130 °C. Under these conditions, we obtained two products **8a** (25%) and **9a** (20%). Compounds **8a** and **9a** were fully characterized by spectroscopic analysis.

![One-Pot Two-Step Synthesis of Tricyclic Benzofuran-Fused Pyridines and Highly Conjugated Fluorescent Alkenes under Microwave Conditions](ao9b04169_0004){#sch6}

We also tried to increase the yield of **8a** using different bases like DBU, K~2~CO~3~, KOH as well as by screening different solvents like MeOH, EtOH, and DMSO, but in all of these cases, the yield of the corresponding alkene did not improve. Compound **9a** is a novel benzofuran-fused pyridine derivative formed by the intramolecular cyclization of a highly conjugated alkene **8a**.

Next, using a similar one-pot reaction, in situ **3c** was generated and on the reaction with malononitrile under the similar reaction conditions, the corresponding alkene **8c** was obtained in 22% along with a trace amount of **9c**. Interestingly, we found that both the alkenes exhibit significant fluoresce properties under the visible and UV lights.

Fluorescence properties of the solutions of **3a** and **8a** as well as **3c** and **8c** under the daylight and UV (short and long wavelengths) are shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. We also measured photophysical properties of **3a** and **3c** along with their corresponding alkenes **8a** and **8c** in DMSO solution at room temperature using quininesulfate dihydrate as the fluorescence reference standard. Considering the poor solubility of **8a** and **8c**, we could not study UV--visible and fluorescence properties of these molecules in other solvents. We observed very good quantum yields Ø~f~ = 0.57 for **8a** and Ø~f~ = 0.68 for **8c** in DMSO medium. However, their corresponding starting materials **3a** and **3c** did not show fluorescence properties ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). The observed results are summarized in [Table [6](#tbl6){ref-type="other"}](#tbl6){ref-type="other"}.

![(From the left to the right side) **3a**, **8a**, **3c**, and **8c** in DMSO (10^--5^ M) under (a) daylight, (b) short-wavelength UV (254 nm), and (c) long-wavelength UV (365 nm).](ao9b04169_0017){#fig3}

![(i) UV--visible spectra of **3a**, **3c**, **8a**, and **8c**. Fluorescence spectra of (ii) **3a** and **8a** and (iii) **3c** and **8c**; (iv) combined spectra of **8a** and **8c** in DMSO (10^--5^ M, 25 °C, slit = 1.5/1.5).](ao9b04169_0011){#fig4}

###### Photophysical Properties of **8a**, **8c**, and Their Corresponding Starting Materials (3-Amino-2-aroyl benzofurans)[a](#t6fn1){ref-type="table-fn"}

  product   λ~max~^abs^ (nm)   λ~max~^em^ (nm)   ΔU̅ (cm^--1^)   Ø~f~
  --------- ------------------ ----------------- -------------- ------
  **3a**    380                                                 ND
  **8a**    392                464               3959           0.57
  **3c**    382                                                 ND
  **8c**    392                465               4005           0.68

Ø~f~ = quantum yield; λ~max~^abs^ = absorbance maxima; λ~max~^em^ = fluorescence maxima; ΔU̅ = Stokes shift.

The proposed reaction pathway for the formation of 3-amino-2-aroyl benzofuran, the corresponding alkene on reaction with malononitrile, and the benzofuran-fused pyridine is shown in [Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}. One equiv of Cs~2~CO~3~ is required for the formation of phenoxide of **1a**, which later reacts with **2a** to form the acyclic intermediate **3a′**. Another 1 equiv of a base is required for the preparation of the carbanion intermediate **P**, which undergoes intramolecular cyclization to give **Q**. Finally, the desired product **3a** forms by tautomerization of **Q**. The formation of alkene **8a** takes place by the Knoevenagel-type condensation between **3a** and malononitrile in the presence of Cs~2~CO~3~ as a base. Considering the presence of both the electrophilic site −CN and the nucleophilic site −NH~2~ in the same molecule of **8a**, in the presence of a base and heating conditions, it further undergoes intramolecular cyclization to provide the fused pyridine **9a**. Similarly, the proposed reaction pathway for the copper-catalyzed *N*-arylation of 3-amino-2-aroyl benzofurans is shown in [Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}. The role of oxygen in this copper-catalyzed *N*-arylation reaction was investigated by performing a reaction of **3a** and phenylboronic acid **4a** in the absence of oxygen (under a nitrogen environment), and we found a drastic decrease in the yield obtained.

![Proposed Mechanism for the Formation of **3a**, **8a**, and **9a**](ao9b04169_0005){#sch7}

![Proposed Mechanism for the *N*-Arylation of **3a**](ao9b04169_0009){#sch8}

Similarly, the reaction of **3a** with **4a** in the presence of 2.0 equiv of TEMPO did not show any change in the yield of **5a**. Thus, we ruled out the possibility of having a mechanism by radical generation. Based on the literature reports,^[@ref26]−[@ref29]^ as well as on the basis of our above observation, we have proposed the most probable mechanism for the copper-catalyzed *N*-arylation reaction involving **T**, **U**, and **V** as intermediates ([Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}).

Conclusions {#sec3}
===========

In summary, we developed an efficient methodology for the rapid synthesis of 3-amino-2-aroyl benzofuran derivatives by the reaction of 2-hydroxybenzonitriles and 2-bromoacetophenone in the presence of Cs~2~CO~3~ as a base within a very short reaction time. The advantages of this protocol are (1) the use of cheap and commercially available substrates, (2) a short reaction time, (3) a room-temperature cascade reaction involving C--C and C--O bond formation in one pot, (4) high yields, (5) a wide substrate scope, and (6) easy purification of products. We also developed a novel and efficient, ligand- and base-free copper(II)-catalyzed room-temperature methodology for the selective *N*-arylation of 3-amino-2-aroyl benzofurans using arylboronic acids as a coupling partner. This method is also a versatile method with a wide substrate scope and can be tuned to achieve bi-*N*-arylated products. In addition to these, we reported a one-pot three-component reaction in the presence of a stoichiometric amount of Cs~2~CO~3~ and of Cu(OAC)~2~ in DMF medium for the synthesis of an *N*-arylated aminobenzofuran derivative directly. Finally, we prepared novel highly fluorescent alkenes and benzofuran-fused aminopyridine from the reaction of malononitrile and 3-amino-2-aroyl benzofurans in the presence of Cs~2~CO~3~ as a base and microwave heating.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All reagents and solvents were procured from TCI chemicals, Sigma-Aldrich, Alfa Aesar, or Rankem and were used without further purification. The progress of the reaction was monitored by thin-layer chromatography (TLC). A PerkinElmer Fourier transform infrared instrument was used for recording IR spectra in the attenuated total reflectance (ATR) mode, and absorption is shown in cm^--1^. A Bruker 400 MHz NMR instrument was used for recording NMR spectra. ^1^H NMR (400 MHz) and ^13^C NMR (100 MHz) spectra were recorded in either CDCl~3~ or DMSO-*d*~6~ solvent at 25 °C. Chemical shift (in ppm) values are reported using tetramethylsilane (δ = 0) as an internal standard in CDCl~3~ (δ = 7.26) or DMSO-*d*~6~ (δ = 2.50) as the solvent. The following abbreviations were used to define multiplicities: s = singlet; d = doublet; t = triplet; m = multiplet; dd: doublet of doublets; td: triplet of doublets; brs: broad singlet. Coupling constants (*J*) are in Hz. A Bruker Impact HD mass spectrometer \[Impact HD UHR-TOF, electrospray ionization (ESI) with the positive ion mode\] and an Agilent 6545 quadrupole time-of-flight (Q-TOF) mass spectrometer were used for HRMS analysis of all of the products. Microwave heating was performed under sealed conditions using a Biotage initiator microwave reactor from Upsala, Sweden, having an inbuilt infrared (IR) external surface temperature sensor. Melting points were recorded using an SRS EZ-Melt automated melting point apparatus by capillary methods without correction.

Experimental Procedures {#sec4.2}
-----------------------

### Typical Experimental Procedure for the Synthesis of **3a′** {#sec4.2.1}

A mixture of 2-hydroxybenzonitrile (0.5 mmol), Cs~2~CO~3~ (0.5 mmol), and 2-bromoacetophenone (0.5 mmol) in 2.0 mL of DMF was stirred at room temperature for 10--20 min in a 10 mL round-bottom flask. After completion of the reaction (monitored by TLC), the mixture was poured in ice. The solid product was separated by just filtration and washed with cold water twice. Finally, the crude product was purified by recrystallization from dichloromethane.

#### 2-(2-Oxo-2-phenylethoxy)benzonitrile (**3a′**) {#sec4.2.1.1}

It was purified by recrystallization from dichloromethane. Yield 109 mg (92%); yellow solid; mp 146--148 °C. IR (ATR) 2972, 2925, 2222, 1685, 1599, 1488, 1450, 1364, 1300, 1220, 1167, 1112, 1065, 965 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.00 (d, *J* = 8.0 Hz, 2H), 7.63 (t, *J* = 8.0 Hz, 1H), 7.57 (d, *J* = 8.0 Hz, 1H), 7.51 (t, *J* = 8.0 Hz, 2H), 7.46 (t, *J* = 8.0 Hz, 1H), 7.02 (t, *J* = 8.0 Hz, 1H), 6.82 (d, *J* = 8.0 Hz, 1H), 5.43 (s, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 193.4, 159.8, 134.4, 134.3, 134.1, 134.0, 129.1, 128.3, 121.8, 116.3, 112.7, 102.5, 71.3 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~11~NO~2~Na \[M + Na\]^+^ 260.0682; found: 260.0691.

### Typical Experimental Procedure for the Synthesis of **3a**--**r** {#sec4.2.2}

A mixture of 2-hydroxybenzonitrile/derivative (0.5 mmol), Cs~2~CO~3~ (1.0 mmol), and 2-bromoacetophenone/derivative (0.5 mmol) in 2.0 mL of DMF was stirred at room temperature for 10--20 min in a 10 mL round-bottom flask. After completion of the reaction (monitored by TLC), the mixture was poured in ice. The solid product was separated by just filtration and washed with cold water twice. Finally, the crude product was purified by either recrystallization from dichloromethane or column chromatography using a mixture of hexane and ethyl acetate as the eluent.

#### (3-Aminobenzofuran-2-yl)(phenyl)methanone (**3a**) {#sec4.2.2.1}

It was purified by recrystallization from dichloromethane. Yield 109 mg (92%); yellow solid; mp 120--122 °C. IR (ATR) 3424, 3299, 3186, 3053, 1632, 1519, 1486, 1452, 1441, 1356, 1320, 1309, 1173, 1106, 968 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.22 (d, *J* = 8.0 Hz, 2H), 7.61(d, *J* = 8.0 Hz, 1H), 7.56--7.47 (m, 4H), 7.43 (d, *J* = 8.0 Hz, 1H), 7.23 (t, *J* = 4.0 Hz, 1H), 6.02 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.4, 154.6, 142.2, 137.9, 135.4, 131.9, 129.9, 129.4, 128.4, 122.5, 121.0, 120.3, 112.9 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~12~NO~2~ \[M + H\]^+^ 238.0863; found 238.0858.

#### (3-Aminobenzofuran-2-yl)(*p*-tolyl)methanone (**3b**) {#sec4.2.2.2}

It was purified by recrystallization from dichloromethane. Yield 110 mg (88%); yellow solid; mp 166--168 °C. IR (ATR) 3438, 3415, 3324, 3271, 3175, 1605, 1505, 1472, 1444, 1347, 1303, 1270, 1165, 1095, 943 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.20 (d, *J* = 8.0 Hz, 2H), 7.65 (d, *J* = 8.0 Hz, 1H), 7.55--7.46 (m, 2H), 7.35 (d, *J* = 8.0 Hz, 2H), 7.28 (t, *J* = 8.0 Hz, 1H), 6.04 (bs, 2H), 2.47 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~) δ 183.2, 154.5, 142.6, 141.9, 135.4, 135.2, 129.8, 129.5, 129.1, 122.4, 121.1, 120.2, 112.8, 21.8 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~14~NO~2~ \[M + H\]^+^ 252.1019; found 252.1025.

#### (3-Aminobenzofuran-2-yl)(3-methoxyphenyl)methanone (**3c**) {#sec4.2.2.3}

It was purified by recrystallization from dichloromethane. Yield 124 mg (93%); yellow solid; mp 126--128 °C. IR (ATR) 3415, 3303, 1610, 1575, 1504, 1471, 1440, 1350, 1311, 1274, 1254, 1236, 1173, 1103, 1035, 875 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 7.91 (d, *J* = 8.0 Hz, 1H), 7.77 (s, 1H), 7.62 (d, *J* = 8.0 Hz, 1H), 7.50--7.41 (m, 3H), 7.21 (t, *J* = 8.0 Hz, 1H), 7.11 (dd, *J* = 8.0, 4.0 Hz, 1H), 6.22 (bs, 2H), 3.88 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.7, 159.5, 154.5, 142.6, 139.1, 135.1, 129.9, 129.3, 122.3, 121.9, 120.8, 120.4, 118.2, 113.9, 112.7, 55.4 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~14~NO~3~ \[M + H\]^+^ 268.0968; found 268.0971.

#### (3-Aminobenzofuran-2-yl)(4-chlorophenyl)methanone (**3d**) {#sec4.2.2.4}

It was purified by recrystallization from dichloromethane. Yield 118 mg (87%); yellow solid; mp 201--203 °C. IR (ATR) 3421, 3296, 3188, 2920, 1608, 1588, 1511, 1444, 1353, 1317, 1273, 1173, 1090, 962 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.22 (d, *J* = 8.0 Hz, 2H), 7.64 (d, *J* = 8.0 Hz, 1H), 7.56--7.45 (m, 4H), 7.29 (d, *J* = 8.0 Hz, 1H), 6.06 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 181.7, 154.6, 142.6, 138.3, 136.2, 135.2, 130.8, 130.2, 128.7, 122.6, 120.8, 120.3, 112.9 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~11~ClNO~2~ \[M + H\]^+^ 272.0473; found 272.0487.

#### (3-Aminobenzofuran-2-yl)(4-nitrophenyl)methanone (**3e**) {#sec4.2.2.5}

It was purified by recrystallization from dichloromethane. Yield 122 mg (86%); yellow solid; mp 209--211 °C. IR (ATR) 3424, 3305, 3191, 2992, 1771, 1613, 1591, 1519, 1480, 1447, 1345, 1314, 1245, 1176, 1104, 1059, 965 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.40--8.35 (m, 4H), 7.67 (d, *J* = 8.0 Hz, 1H), 7.59--7.55 (m, 1H), 7.47 (d, *J* = 12.0 Hz, 1H), 7.31 (dt, *J* = 8.0, 4.0 Hz, 1H), 6.20 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 180.3, 155.0, 149.6, 143.7, 142.9, 135.1, 130.9, 130.3, 123.6, 122.9, 120.5, 113.0 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~11~N~2~O~4~ \[M + H\]^+^ 283.0713; found 283.0710.

#### (3-Aminobenzofuran-2-yl)(naphthalen-2-yl)methanone (**3f**) {#sec4.2.2.6}

It was purified by recrystallization from dichloromethane. Yield 128 mg (89%); yellow solid; mp 167--169 °C. IR (ATR) 3409, 3276, 1608, 2925, 1608, 1505, 1472, 1445, 1422, 1356, 1306, 1276, 1239, 1170, 1103, 1034, 904 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.85 (s, 1H), 8.29 (d, *J* = 8.0 Hz, 1H), 8.03 (d, *J* = 8.0 Hz, 1H), 7.96 (d, *J* = 12.0 Hz, 1H), 7.89 (d, *J* = 8.0 Hz, 1H), 7.64--7.47 (m, 5H), 7.24 (t, *J* = 8.0 Hz, 1H), 6.22 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ = 183.0, 154.6, 142.5, 135.5, 135.1, 132.7, 130.8, 130.0, 129.7, 128.1, 128.0, 127.8, 126.5, 125.4, 122.4, 120.9, 120.3, 112.8 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~19~H~14~NO~2~ \[M + H\]^+^ 288.1019; found 288.1025.

#### (3-Amino-5-bromobenzofuran-2-yl)(phenyl)methanone (**3g**) {#sec4.2.2.7}

It was purified by recrystallization from dichloromethane. Yield 139 mg (88%); yellow solid; mp 173--175 °C. IR (ATR) 3427, 3302, 1619, 1519, 1497, 1486, 1419, 1309, 1295, 1273, 1178, 1112, 954, 882 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.21 (d, *J* = 8.0 Hz, 2H), 7.77 (s, 1H), 7.60--7.51 (m, 4H), 7.34 (d, *J* = 8.0 Hz, 1H), 5.97 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.6, 153.1, 140.9, 137.6, 135.9, 132.8, 132.2, 129.4, 128.4, 123.0, 122.9, 115.3, 114.5 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~11~BrNO~2~ \[M + H\]^+^ 315.9968; found 315.9956.

#### (3-Amino-5-bromobenzofuran-2-yl)(*p*-tolyl)methanone (**3h**) {#sec4.2.2.8}

It was purified by recrystallization from dichloromethane. Yield 149 mg (90%); yellow solid; mp 182--184 °C. IR (ATR) 3427, 3316, 1610, 1491, 1417, 1345, 1306, 1176, 1109, 1051, 957 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.14 (d, *J* = 8.0 Hz, 2H), 7.76 (s, 1H), 7.58 (d, *J* = 8.0 Hz, 1H), 7.33 (s, 3H), 5.92 (bs, 2H), 2.45 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.4, 153.0, 142.9, 140.5, 136.1, 134.9, 132.6, 129.5, 129.2, 123.0, 122.9, 115.3, 114.4, 21.8 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~13~BrNO~2~ \[M + H\]^+^ 330.0124; found 330.0131.

#### (3-Amino-5-bromobenzofuran-2-yl)(3-methoxyphenyl)methanone (**3i**) {#sec4.2.2.9}

It was purified by recrystallization from dichloromethane. Yield 163 mg (94%); yellow solid; mp 142--144 °C. IR (ATR) 3465, 3353, 3323, 1614, 1515, 1468, 1432, 1356, 1306, 1236, 1176, 1153, 1120, 911 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 7.84 (d, *J* = 8.0 Hz, 1H), 7.72 (d, *J* = 8.0 Hz, 2H), 7.52 (d, *J* = 8.0 Hz, 1H), 7.41 (t, *J* = 8.0 Hz, 1H), 7.27 (d, *J* = 8.0 Hz, 1H), 7.09 (d, *J* = 8.0 Hz, 1H), 6.15 (bs, 2H), 3.87 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.9, 159.6, 153.0, 141.3, 138.7, 135.7, 132.7, 129.4, 123.1, 122.7, 121.9, 118.4, 115.2, 114.3, 113.9, 55.5 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~13~BrNO~3~ \[M + H\]^+^ 346.0073; found 346.0080.

#### (3-Amino-5-bromobenzofuran-2-yl)(4-chlorophenyl)methanone (**3j**) {#sec4.2.2.10}

It was purified by recrystallization from dichloromethane. Yield 151 mg (86%); yellow solid; mp 218--220 °C. IR (ATR) 3429, 3319, 1624, 1608, 1511, 1486, 1417, 1311, 1303, 1275, 1178, 1112, 1093, 1015, 968 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.17 (d, *J* = 8.0 Hz, 2H), 7.77 (s, 1H), 7.61 (dd, *J* = 8.0, 4.0 Hz, 1H), 7.50--7.48 (m, 2H), 7.34 (d, *J* = 8.0 Hz, 1H), 5.98 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 181.9, 153.1, 141.2, 138.6, 135.9, 135.8, 133.1, 130.9, 128.8, 123.1, 122.8, 115.5, 114.5 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~10~BrClNO~2~ \[M + H\]^+^ 349.9578; found 349.9587.

#### (3-Amino-5-bromobenzofuran-2-yl)(4-nitrophenyl)methanone (**3k**) {#sec4.2.2.11}

It was purified by recrystallization from dichloromethane. Yield 154 mg (85%); yellow solid; mp 238--240 °C. IR (ATR) 3427, 3319, 1624, 1610, 1522, 1505, 1419, 1347, 1309, 1187, 1142, 1109, 1012, 965 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.36 (s, 4H), 7.81 (d, *J* = 4.0 Hz, 1H), 7.64 (dd, *J* = 8.0, 4.0 Hz, 1H), 7.36 (d, *J* = 8.0 Hz, 1H), 6.13 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 180.7, 153.5, 149.7, 142.6, 142.3, 135.6, 133.7, 130.3, 123.6, 123.3, 122.4, 115.7, 114.6 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~10~BrN~2~O~4~ \[M + H\]^+^ 360.9818; found 360.9811.

#### (3-Amino-5-bromobenzofuran-2-yl)(naphthalen-2-yl)methanone (**3l**) {#sec4.2.2.12}

It was purified by recrystallization from dichloromethane. Yield 162 mg (88%); yellow solid; mp 153--155 °C. IR (ATR) 3416, 3293, 2921, 1604, 1584, 1508, 1488, 1415, 1309, 1269, 1173, 1150, 1117, 1050, 931 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.81 (s, 1H), 8.24 (dd, *J* = 8.0, 2.0 Hz, 1H), 8.03 (d, *J* = 4.0 Hz, 1H), 7.95 (d, *J* = 8.0 Hz, 1H), 7.89 (d, *J* = 8.0 Hz, 1H), 7.77 (d, *J* = 2.0 Hz, 1H), 7.62--7.53 (m, 3H), 7.37 (d, *J* = 8.0 Hz, 1H), 6.01 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.3, 153.1, 141.0, 136.2, 135.2, 134.8, 132.8, 132.7, 130.8, 129.8, 128.2, 128.1, 127.9, 126.6, 125.3, 123.1, 122.9, 115.4, 114.5 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~19~H~13~BrNO~2~ \[M + H\]^+^ 366.0124; found 366.0143.

#### (3-Amino-4-fluorobenzofuran-2-yl)(phenyl)methanone (**3m**) {#sec4.2.2.13}

It was purified by recrystallization from dichloromethane. Yield 109 mg (86%); yellow solid; mp 93--95 °C. IR (ATR) 3412, 3303, 1608, 1515, 1478, 1458, 1356, 1299, 1239, 1183, 1156, 1040, 954 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.23--8.20 (m, 2H), 7.57--7.48 (m, 3H), 7.40--7.35 (m, 1H), 7.18 (d, *J* = 8.0 Hz, 1H), 6.85 (dd, *J* = 8.0, 4.0 Hz, 1H), 6.24 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.8, 157.8 (d, *J*~(C--F)~ = 250.0 Hz), 155.5 (d, *J*~(C--F)~ = 8.0 Hz), 140.67(d, *J*~(C--F)~ = 2.0 Hz), 137.54, 134.55 (d, *J*~(C--F)~ = 1.0 Hz), 131.95, 130.4 (d, *J*~(C--F)~ = 9.0 Hz), 129.19, 128.30, 110.6 (d, *J*~(C--F)~ = 18.0 Hz), 108.8 (d, *J*~(C--F)~ = 4.0 Hz), 107.7 (d, *J*~(C--F)~ = 18.0 Hz) ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~11~FNO~2~ \[M + H\]^+^ 256.0768; found 256.0769.

#### (3-Amino-4-fluorobenzofuran-2-yl)(3-methoxyphenyl)methanone (**3n**) {#sec4.2.2.14}

It was purified by recrystallization from dichloromethane. Yield 132 mg (92%); yellow solid; mp 92--94 °C. IR (ATR) 3422, 3316, 2928, 1614, 1578, 1511, 1455, 1356, 1296, 1239, 1143, 1034, 994 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 7.87 (d, *J* = 4.0 Hz, 1H), 7.73 (s, 1H), 7.45--7.38 (m, 2H), 7.21 (d, *J* = 8.0 Hz, 1H), 7.11 (dd, *J* = 8.0 Hz, *J* = 4.0 Hz, 1H), 6.87 (t, *J* = 8.0 Hz, 1H), 6.28 (bs, 2H), 3.90 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.4, 159.6, 157.8 (d, *J*~(C--F)~ = 250.0 Hz), 155.5 (d, *J*~(C--F)~ = 8.0 Hz), 140.9(d, *J*~(C--F)~ = 2.0 Hz), 138.8, 134.5, 130.5 (d, *J*~(C--F)~ = 8.0 Hz), 129.3, 121.9, 118.3, 113.8, 110.6 (d, *J*~(C--F)~ = 19.0 Hz), 108.8 (d, *J*~(C--F)~ = 4.0 Hz), 107.8 (d, *J*~(C--F)~ = 18.0 Hz), 55.4 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~13~FNO~3~ \[M + H\]^+^ 286.0874; found 286.0868.

#### (3-Amino-4-fluorobenzofuran-2-yl)(4-chlorophenyl)methanone (**3o**) {#sec4.2.2.15}

It was purified by recrystallization from dichloromethane. Yield 123 mg (85%); yellow solid; mp 145--147 °C. IR (ATR) 3409, 3310, 1621, 1588, 1568, 1518, 1482, 1452, 1359, 1312, 1299, 1239, 1180, 1090, 1044, 1014, 964 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.18 (d, *J* = 8.0 Hz, 2H), 7.50 (d, *J* = 8.0 Hz, 2H), 7.46--7.42(m, 1H), 7.24 (t, *J* = 8.0 Hz, 1H), 6.90 (dd, *J* = 8.0, 4.0 Hz, 1H), 6.26 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 181.4, 157.8 (d, *J*~(C--F)~ = 250.0 Hz), 155.5 (d, *J*~(C--F)~ = 9.0 Hz), 141.2 (d, *J*~(C--F)~ = 2.0 Hz), 138.4, 135.9, 134.5, 130.8 (d, *J*~(C--F)~ = 8.0 Hz), 129.1, 128.7, 110.5 (d, *J*~(C--F)~ = 18.0 Hz), 108.8 (d, *J*~(C--F)~ = 4.0 Hz), 107.9 (d, *J*~(C--F)~ = 18.0 Hz) ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~10~ClFNO~2~ \[M + H\]^+^ 290.0379; found 290.0377.

#### (3-Amino-4-fluorobenzofuran-2-yl)(4-nitrophenyl)methanone (**3p**) {#sec4.2.2.16}

It was purified by recrystallization from dichloromethane. Yield 125 mg (83%); yellow solid; mp 162--164 °C. IR (ATR) 3409, 3303, 1740, 1611, 1511, 1485, 1452, 1352, 1299, 1239, 1147, 1040, 868 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.34 (s, 4H), 7.51--7.45 (m, 1H), 7.23 (d, *J* = 8.0 Hz, 1H), 6.92 (t, *J* = 8.0 Hz, 1H), 6.39 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 179.9, 157.9 (d, *J*~(C--F)~ = 251.0 Hz), 155.9 (d, *J*~(C--F)~ = 8.0 Hz), 149.6, 142.6, 142.2, 134.4, 131.5 (d, *J*~(C--F)~ = 8.0 Hz), 130.2, 123.5, 110.4 (d, *J*~(C--F)~ = 18.0 Hz), 109.0 (d, *J*~(C--F)~ = 4.0 Hz), 108.2 (d, *J*~(C--F)~ = 18.0 Hz) ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~15~H~10~FN~2~O~4~ \[M + H\]^+^ 301.0619; found 301.0620.

#### (3-Amino-4-fluorobenzofuran-2-yl)(naphthalen-2-yl)methanone (**3q**) {#sec4.2.2.17}

It was purified by recrystallization from dichloromethane. Yield 130 mg (85%); yellow solid; mp 104--106 °C. IR (ATR) 3505, 3356, 3054, 1614, 1515, 1472, 1356, 1302, 1236, 1176, 1156, 1117, 1040, 911 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.80 (s, 1H), 8.26 (d, *J* = 12.0 Hz, 1H), 8.01 (d, *J* = 8.0 Hz, 1H), 7.93 (d, *J* = 8.0 Hz, 1H), 7.87 (d, *J* = 8.0 Hz, 1H), 7.59--7.52 (m, 2H), 7.40--7.36 (m, 1H), 7.23 (d, *J* = 12.0 Hz, 1H), 6.87 (t, *J* = 8.0, 1H), 6.28 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.6, 157.8 (d, *J*~(C--F)~ = 250.0 Hz), 155.5 (d, *J*~(C--F)~ = 8.0 Hz), 140.7(d, *J*~(C--F)~ = 2.0 Hz), 135.1, 134.8, 132.7, 130.6, 130.4 (d, *J*~(C--F)~ = 8.0 Hz), 129.7, 128.1, 128.0, 127.7, 126.5, 125.3, 110.6 (d, *J*~(C--F)~ = 18.0 Hz), 108.8 (d, *J*~(C--F)~ = 4.0 Hz), 107.8 (d, *J*~(C--F)~ = 18.0 Hz) ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~19~H~13~FNO~2~ \[M + H\]^+^ 306.0925; found 306.0929.

#### 4-(3-Amino-4-fluorobenzofuran-2-carbonyl)benzonitrile (**3r**) {#sec4.2.2.18}

It was purified by recrystallization from dichloromethane. Yield 118 mg (84%); yellow solid; mp 199--201 °C. IR (ATR) 3440, 3412, 3311, 3089, 3072, 3047, 2227, 1620, 1597, 1555, 1518, 1476, 1457, 1358, 1316, 1302, 1288, 1243, 1192, 1176, 1041, 942 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.29 (d, *J* = 8.0 Hz, 2H), 7.81 (d, *J* = 8.0 Hz, 2H), 7.50--7.45 (m, 1H), 7.23 (d, *J* = 8.0 Hz, 1H), 6.95--6.90 (m, 1H), 6.36 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 180.4, 157.9 (d, *J*~(C--F)~ = 250.0 Hz), 155.8(d, *J*~(C--F)~ = 8.0 Hz), 142.0, 141.1, 134.4, 132.2, 131.3 (d, *J*~(C--F)~ = 9.0 Hz), 129.7, 118.5, 115.2, 110.4 (d, *J*~(C--F)~ = 18.0 Hz), 109.0 (d, *J*~(C--F)~ = 4.0 Hz), 108.2 (d, *J*~(C--F)~ = 18.0 Hz) ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~10~FN~2~O~2~ \[M + H\]^+^ 281.0721; found 281.0712.

### Typical Experimental Procedure for the Synthesis of **5a** {#sec4.2.3}

A mixture of (3-aminobenzofuran-2-yl)(phenyl)methanone **3a** (0.5 mmol) and phenylboronic acid **4a** (0.6 mmol) in 2.0 mL of dichloromethane and 10 mol % Cu(OAc)~2~ was stirred in a 10 mL round-bottom flask at room temperature. The progress of the reaction was monitored by TLC. After completion of the reaction, the solvent was removed by the rota vapor and the crude product was purified by column chromatography (hexane/ethyl acetete, 99:1). The purified product was characterized by NMR spectroscopy, electrospray ionization mass spectrometry (ESI-MS), and IR techniques. Using a similar procedure, we prepared all other products given in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}.

#### Phenyl(3-(phenylamino)benzofuran-2-yl)methanone (**5a**) {#sec4.2.3.1}

Eluent: hexane/ethyl acetate (49:1). Yield 115 mg (73%); yellow solid; mp 108--110 °C. IR (ATR) 3277, 2921, 2850, 1608, 1592, 1572, 1552, 1502, 1459, 1445, 1400, 1299, 1285, 1268, 1240, 1176, 1164, 1103, 1021, 1004, 903 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.73 (s, 1H), 8.28 (d, *J* = 8.0 Hz, 2H), 7.61--7.54 (m, 3H), 7.50--7.45 (m, 2H), 7.40 (t, *J* = 8.0 Hz, 2H), 7.32 (d, *J* = 8.0 Hz, 3H), 7.22 (t, *J* = 8.0 Hz, 1H), 7.10--7.05 (m, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.3, 155.2, 140.4, 140.1, 137.8, 136.9, 132.1, 129.7, 129.5, 129.4, 128.5, 124.9, 124.2, 123.3, 122.1, 120.2, 112.9 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~21~H~16~NO~2~ \[M + H\]^+^ 314.1176; found: 314.1181.

#### Phenyl(3-(*p*-tolylamino)benzofuran-2-yl)methanone (**5b**) {#sec4.2.3.2}

Eluent: hexane/ethyl acetate (49:1). Yield 121 mg (74%); yellow solid; mp 108--110 °C. IR (ATR) 3241, 2921, 2853, 1602, 1574, 1537, 1515, 1451, 1437, 1386, 1295, 1268, 1235, 1178, 1153, 1103, 1018, 937 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.72 (s, 1H), 8.29 (dd, *J* = 8.0, 4.0 Hz, 2H), 7.60--7.52 (m, 3H), 7.48--7.43 (m, 2H), 7.24--7.21 (m, 5H), 7.07--7.04 (m, 1H), 2.40 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 182.8, 155.2, 141.1, 137.8, 137.3, 136.5, 134.9, 131.9, 129.9, 129.7, 129.4, 128.4, 124.2, 123.8, 121.9, 120.1, 112.8, 21.10 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~22~H~18~NO~2~ \[M + H\]^+^ 328.1332; found: 328.1336.

#### (3-((4-(*tert*-Butyl)phenyl)amino)benzofuran-2-yl)(phenyl)methanone (**5c**) {#sec4.2.3.3}

Eluent: hexane/ethyl acetate (49:1). Yield 141 (76%); yellow solid; mp 130--132 °C. IR (ATR) 3255, 2963, 2859, 1608, 1586, 1575, 1544, 1454, 1384, 1367, 1294, 1274, 1240, 1223, 1159, 1103, 1018, 1004, 878 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.78 (s, 1H), 8.29 (dd, *J* = 8.0, 4.0 Hz, 2H), 7.59--7.54 (m, 3H), 7.48--7.47 (m, 2H), 7.43 (d, *J* = 8.0 Hz, 2H), 7.33 (d, *J* = 8.0 Hz, 1H), 7.28 (d, *J* = 8.0 Hz, 2H), 7.10--7.06 (m, 1H), 1.39 (s, 9H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.9, 155.2, 148.1, 140.8, 137.8, 137.3, 136.6, 131.9, 129.7, 129.4, 128.4, 126.1, 124.3, 123.1, 121.9, 120.1, 112.8, 34.6, 31.6 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~25~H~24~NO~2~ \[M + H\]^+^ 370.1802; found: 370.1808.

#### (3-((4-Methoxyphenyl)amino)benzofuran-2-yl)(phenyl)methanone (**5d**) {#sec4.2.3.4}

Eluent: hexane/ethyl acetate (49:1). Yield 134 mg (78%); yellow solid; mp 147--149 °C. IR (ATR) 3289, 2923, 1606, 1572, 1532, 1510, 1448, 1434, 1372, 1325, 1294, 1268, 1236, 1212, 1178, 1159, 1100, 1032, 1021, 1004, 875 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.68 (s, 1H), 8.29 (d, *J* = 8.0 Hz, 2H), 7.5--7.55 (m, 3H), 7.45--7.42 (m, 2H), 7.29 (d, *J* = 8.0 Hz, 2H), 7.09 (d, *J* = 8.0 Hz, 1H), 7.04--7.01 (m, 1H), 6.95 (d, *J* = 8.0 Hz, 2H), 3.86 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.5, 157.7, 155.2, 142.1, 137.8, 136.0, 132.7, 131.8, 129.7, 129.3, 128.3, 126.2, 123.9, 121.9, 119.9, 114.5, 112.7, 55.6 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~22~H~18~NO~3~ \[M + H\]^+^ 344.1281; found: 344.1296.

#### (3-(Naphthalen-2-ylamino)benzofuran-2-yl)(phenyl)methanone (**5e**) {#sec4.2.3.5}

Eluent: hexane/ethyl acetate (49:1). Yield 140 mg (77%); yellow solid; mp 182--184 °C. IR (ATR) 3058, 2921, 2853, 1606, 1569, 1549, 1454, 1384, 1294, 1277, 1232, 1173, 1136, 1103, 1021, 1004, 869 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 10.14 (s, 1H), 8.35 (dd, *J* = 8.0, 2.0 Hz, 2H), 8.31--8.29 (m, 1H), 7.95 (dd, *J* = 8.0, 4.0 Hz, 1H), 7.81 (d, *J* = 8.0 Hz, 1H), 7.62--7.54 (m, 5H), 7.52--7.48 (m, 3H), 7.46--7.41 (m, 1H), 6.99--6.93 (m, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.3, 155.3, 141.7, 137.8, 136.9, 136.0, 134.6, 132.1, 129.7, 129.5, 129.4, 128.5, 128.4, 126.8, 126.7, 126.1, 125.6, 124.1, 122.8, 122.1, 120.9, 120.0, 112.9 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~25~H~18~NO~2~ \[M + H\]^+^ 364.1332; found: 364.1341.

#### (3-((4-Bromophenyl)amino)benzofuran-2-yl)(phenyl)methanone (**5f**) {#sec4.2.3.6}

Eluent: hexane/ethyl acetate (49:1). Yield 138 mg (70%); yellow solid; mp 155--157 °C. IR (ATR) 3269, 3064, 2921, 2850, 1606, 1572, 1535, 1488, 1448, 1434, 1384, 1305, 1291, 1271, 1235, 1178, 1162, 1103, 1069, 1001, 875 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.62 (s, 1H), 8.27 (d, *J* = 8.0 Hz, 2H), 7.61--7.53 (m, 3H), 7.49 (d, *J* = 8.0 Hz, 4H), 7.32 (d, *J* = 8.0 Hz, 1H), 7.18 (d, *J* = 8.0 Hz, 2H), 7.14--7.10 (m, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.6, 155.1, 139.4, 139.3, 137.5, 137.3, 132.4, 132.3, 129.8, 129.5, 128.5, 124.3, 123.9, 122.3, 120.0, 117.4, 113.0 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~21~H~15~BrNO~2~ \[M + H\]^+^ 392.0281; found: 392.0279.

#### Phenyl(3-((4-(trifluoromethyl)phenyl)amino)benzofuran-2-yl)methanone (**5g**) {#sec4.2.3.7}

Eluent: hexane/ethyl acetate (49:1). Yield 132 mg (69%); yellow solid; mp 118--120 °C. IR (ATR) 3277, 3067, 2921, 2853, 1606, 1572, 1538, 1451, 1437, 1398, 1316, 1291, 1271, 1240, 1170, 1108, 1060, 1015, 1004, 875 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.67 (s, 1H), 8.28 (d, *J* = 8.0 Hz, 2H), 7.63--7.60 (m, 3H), 7.57 (d, *J* = 8.0 Hz, 2H), 7.53 (t, *J* = 8.0 Hz, 2H), 7.44 (d, *J* = 8.0 Hz, 1H), 7.33 (d, *J* = 8.0 Hz, 2H), 7.20--7.16 (m, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 184.2, 154.9, 143.7, 138.1, 137.7, 137.3, 131.2 (q, *J*~(C--F)~ = 279.0 Hz), 129.6, 128.5, 126.6 (q, *J*~(C--F)~ = 4.0 Hz), 125.8, 125.5 (q, *J*~(C--F)~ = 33.0 Hz), 123.9, 123.1, 122.6, 120.8, 120.3, 113.2 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~22~H~15~F~3~NO~2~ \[M + H\]^+^ 382.1049; found: 382.1050.

#### (3-Methoxyphenyl)(3-(phenylamino)benzofuran-2-yl)methanone (**5i**) {#sec4.2.3.8}

Eluent: hexane/EtOAc (49:1). Yield 127 mg (74%); yellow solid; mp 80--82 °C. IR (ATR) 3286, 2926, 2853, 1690, 1596, 1574, 1538, 1460, 1443, 1389, 1288, 1271, 1150, 1103, 1024, 881 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.75 (s, 1H), 7.93 (d, *J* = 8.0 Hz, 1H), 7.78 (s, 1H), 7.48--7.45 (m, 3H), 7.40 (t, *J* = 8.0 Hz, 2H), 7.33--7.28 (m, 3H), 7.22 (t, *J* = 8.0 Hz, 1H), 7.14 (dd, *J* = 8.0, 4.0 Hz, 1H), 7.07--7.05 (m, 1H), 3.92 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.8, 159.7, 155.2, 140.6, 140.0, 139.0, 136.9, 129.8, 129.5, 129.4, 124.9, 124.2, 123.3, 122.2, 122.1, 120.1, 118.5, 113.9, 112.9, 55.6 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~22~H~18~NO~3~ \[M + H\]^+^ 344.1281; found: 344.1286.

#### Naphthalen-2-yl(3-(phenylamino)benzofuran-2-yl)methanone (**5j**) {#sec4.2.3.9}

Eluent: hexane/ethyl acetate (49:1). Yield 135 mg (74%); yellow solid; mp 160--162 °C. IR (ATR) 3053, 2926, 2853, 2671, 2339, 2089, 1738, 1597, 1583, 1572, 1535, 1499, 1462, 1440, 1386, 1333, 1232, 1271, 1201, 1173, 1122, 1027, 1004, 909 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.83 (s, 1H), 8.90 (s, 1H), 8.33 (d, *J* = 8.0 Hz, 1H), 8.07 (d, *J* = 8.0 Hz, 1H), 8.0 (d, *J* = 12.0 Hz, 1H), 7.93 (d, *J* = 8.0 Hz, 1H), 7.64--7.56 (m, 2H), 7.55--7.48 (m, 2H), 7.42 (t, *J* = 8.0 Hz, 2H), 7.35 (t, *J* = 8.0 Hz, 3H), 7.24 (t, *J* = 8.0 Hz, 1H), 7.10 (t, *J* = 8.0 Hz, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 182.9, 155.2, 140.4, 140.1, 137.2, 135.2, 135.0, 132.7, 130.9, 129.8, 129.7, 129.3, 128.1, 127.8, 126.6, 125.5, 124.8, 124.2, 123.2, 122.1, 120.1, 112.9 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~25~H~18~NO~2~ \[M + H\]^+^ 364.1332; found: 364.1334.

#### (5-Bromo-3-(phenylamino)benzofuran-2-yl)(phenyl)methanone (**5k**) {#sec4.2.3.10}

Eluent: hexane/ethyl acetate (49:1). Yield 138 mg (70%); yellow solid; mp 142--144 °C. IR (ATR) 3277, 3055, 2921, 2853, 1606, 1597, 1541, 1493, 1473, 1443, 1409, 1364, 1305, 1268, 1212, 1173, 1142, 1108, 1013, 909 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.61 (s, 1H), 8.23 (d, *J* = 8.0 Hz, 2H), 7.61--7.52 (m, 4H), 7.43--7.35 (m, 4H), 7.28 (d, *J* = 8.0 Hz, 2H), 7.24 (t, *J* = 8.0 Hz, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.5, 153.7, 139.7, 139.1, 137.6, 137.5, 132.6, 132.3, 129.5, 129.4, 128.5, 126.5, 125.3, 123.2, 122.0, 114.9, 114.5 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~21~H~15~BrNO~2~ \[M + H\]^+^ 392.0281; found: 392.0288.

#### (5-Bromo-3-(phenylamino)benzofuran-2-yl)(naphthalen-2-yl)methanone (**5l**) {#sec4.2.3.11}

Eluent: hexane/ethyl acetate (49:1). Yield 162 mg (73%); yellow solid; mp 134--136 °C. IR (ATR) 3275, 2923, 2853, 2668, 2322, 1738, 1594, 1572, 1538, 1502, 1479, 1414, 1378, 1313, 1280, 1266, 1232, 1201, 1170, 1111, 1010, 965 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 9.72 (s, 1H), 8.87 (s, 1H), 8.29 (d, *J* = 8.0 Hz, 1H), 8.07 (d, *J* = 8.0 Hz, 1H), 8.00 (d, *J* = 8.0 Hz, 1H), 7.94 (d, *J* = 8.0 Hz, 1H), 7.66--7.58 (m, 3H), 7.47--7.41 (m, 4H), 7.34--7.28 (m, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.1, 153.7, 139.6, 139.1, 137.8, 135.3, 134.7, 132.7, 132.6, 131.0, 129.8, 129.5, 128.3, 128.2, 127.9, 126.7, 126.5, 125.3, 125.2, 123.1, 122.0, 114.9, 114.5 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~25~H~17~BrNO~2~ \[M + H\]^+^ 442.0437; found: 442.0441.

### Typical Experimental Procedure for the Synthesis of **6a** {#sec4.2.4}

A mixture of (3-aminobenzofuran-2-yl) (phenyl)methanone **3a** (0.5 mmol), phenylboronic acid **4a** (1.25 mmol), and 10 mol% Cu(OAc)~2~ in 2.0 mL of methanol was placed in a 10.0 mL round-bottom flask and stirred at room temperature. The progress of the reaction was monitored by TLC. After completion of the reaction, the solvent was removed by a rota vapor and the crude product was purified by column chromatography (hexane/ethyl acetate, 99:1). The purified product was fully characterized by NMR, ESI-MS, and IR techniques. Using a similar procedure, we prepared all other products given in [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}.

#### (3-(Diphenylamino)benzofuran-2-yl)(phenyl)methanone (**6a**) {#sec4.2.4.1}

Eluent: hexane/ethyl acetate (49:1). Yield 129 mg (66%); yellow semisolid. IR (ATR) 3061, 2923, 2850, 1636, 1589, 1541, 1489, 1445, 1398, 1341, 1288, 1275, 1228, 1176, 1150, 1105, 1010, 976 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 7.70 (d, *J* = 4.0 Hz, 2H), 7.59 (d, *J* = 8.0 Hz, 1H), 7.47--7.42 (m, 2H), 7.32 (t, *J* = 8.0 Hz, 2H), 7.15 (t, *J* = 8.0 Hz, 4H), 7.08 (t, *J* = 8.0 Hz, 1H), 7.00--6.94 (m, 6H), 6.85 (d, *J* = 8.0 Hz, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 184.1, 154.9, 146.7, 143.6, 138.2, 135.2, 132.3, 129.2, 129.1, 128.5, 128.3, 125.1, 123.3, 123.0, 122.5, 112.9 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~27~H~20~NO~2~ \[M + H\]^+^ 390.1489; found: 390.1497.

#### (3-(bis(4-(*tert*-Butyl)phenyl)amino)benzofuran-2-yl)(phenyl)methanone (**6c**) {#sec4.2.4.2}

Eluent: hexane/ethyl acetate (49:1). Yield 168 mg (67%); yellow solid; mp 148--150 °C. IR (ATR) 2954, 2923, 2856, 1634, 1594, 1547, 1507, 1445, 1392, 1291, 1268, 1235, 1167, 1153, 1108, 1007, 976 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 7.59 (t, *J* = 8.0 Hz, 3H), 7.46--7.40 (m, 2H), 7.28 (t, *J* = 8.0 Hz, 2H), 7.12--7.06 (m, 5H), 6.84--6.78 (m, 5H), 1.30 (s, 18H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 184.7, 155.1, 145.9, 144.3, 143.1, 138.5, 135.6, 131.9, 128.8, 128.3, 128.2, 126.0, 125.3, 123.2, 123.1, 121.9, 112.9, 34.4, 31.5 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~35~H~36~NO~2~ \[M + H\]^+^ 502.2741; found: 502.2743.

#### (3-(bis(4-Methoxyphenyl)amino)benzofuran-2-yl)(phenyl)methanone (**6d**) {#sec4.2.4.3}

Eluent: hexane/ethyl acetate (49:1). Yield 153 mg (68%); yellow solid; mp 70--72 °C. IR (ATR) 2926, 2850, 1633, 1504, 1448, 1399, 1294, 1241, 1178, 1150, 1133, 1108, 1033, 826 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 7.71 (d, *J* = 8.0 Hz, 2H), 7.54 (d, *J* = 8.0 Hz, 1H), 7.47--7.40 (m, 3H), 7.34 (t, *J* = 8.0 Hz, 2H), 7.05 (t, *J* = 8.0 Hz, 1H), 6.88--6.85 (m, 4H), 6.78 (d, *J* = 8.0 Hz, 1H), 6.69 (d, *J* = 8.0 Hz, 3H), 3.76 (s, 6H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.7, 155.7, 154.9, 142.4, 140.7, 138.5, 136.3, 132.1, 129.1, 128.4, 128.2, 125.1, 123.9, 123.3, 123.0, 114.6, 112.9, 55.6 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~29~H~24~NO~4~ \[M + H\]^+^ 450.1700; found: 450.1712.

#### (3-(Diphenylamino)benzofuran-2-yl)(3-methoxyphenyl)methanone (**6i**) {#sec4.2.4.4}

Eluent: hexane/ethyl acetate (49:1). Yield 137 mg (65%); yellow semisolid. IR (ATR): 2923, 2853, 1636, 1588, 1548, 1488, 1462, 1426, 1395, 1289, 1262, 1229, 1214, 1150, 1044, 1015, 872 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 7.59 (d, *J* = 8.0 Hz, 1H), 7.44 (t, *J* = 8.0 Hz, 1H), 7.36 (d, *J* = 8.0 Hz, 1H), 7.22 (t, *J* = 8.0 Hz, 1H), 7.15 (t, *J* = 8.0 Hz, 4H), 7.08 (t, *J* = 8.0 Hz, 1H), 7.03 (s, 1H), 7.01--6.93 (m, 7H), 6.83 (d, *J* = 8.0 Hz, 1H), 3.72 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 184.0, 159.8, 154.9, 146.7, 143.6, 139.6, 135.3, 129.3, 129.1, 128.5, 125.1, 123.3, 123.1, 122.5, 121.7, 119.5, 113.0, 112.4, 55.4 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~22~NO~3~ \[M + H\]^+^ 420.1594; found: 420.1599.

### General Procedure for the Preparation of **7a** {#sec4.2.5}

A mixture of (3-amino-5-bromobenzofuran-2-yl)(phenyl)methanone **3g** (0.5 mmol), phenylboronic acid **4a** (0.6 mmol), 10 mol% Cu(OAc)~2~, and K~2~CO~3~ (2.0 equiv) in 3.0 mL of methanol was placed in a 10.0 mL round -bottom flask and stirred at room temperature. The progress of the reaction was monitored by TLC. After completion of the reaction, the solvent was removed by a rota vapor. Next, 10.0 mL of water and 15.0 mL of dichloromethane were added to that residue and the organic layer was separated by a separation funnel. Solvent extraction was done one more time, and the combined organic extract was dried over anhydrous sodium sulfate. Finally, the combined organic extract was removed using a rota vapor and the resultant crude product was purified by column chromatography (hexane/ethyl acetate, 99:1).

#### (3-Amino-5-phenylbenzofuran-2-yl)(phenyl)methanone (**7a**) {#sec4.2.5.1}

Eluent: hexane/ethyl acetate (9:1). Yield 116 mg (74%); yellow solid; mp 140--144 °C. IR (ATR) 3432, 3314, 3179, 3058, 2923, 2850, 1617, 1516, 1488, 1454, 1417, 1325, 1280, 1176, 1111, 1074, 959 cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ 8.26 (d, *J* = 8.0 Hz, 2H), 7.80 (s, 1H), 7.76 (d, *J* = 8.0 Hz, 1H), 7.62 (d, *J* = 8.0 Hz, 2H), 7.58--7.51 (m, 4H), 7.48 (t, *J* = 8.0 Hz, 2H), 7.38 (t, *J* = 8.0 Hz, 1H), 6.05 (bs, 2H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 183.4, 154.2, 142.2, 140.9, 137.9, 136.4, 135.9, 132.0, 129.7, 129.4, 129.1, 128.4, 127.5, 127.5, 121.4, 118.5, 113.1 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~21~H~16~NO~2~ \[M + H\]^+^ 314.1176; found: 314.1179.

### Typical Experimental Procedure for the One-Pot Synthesis of Alkene **8a** and Fused Pyridine **9a** {#sec4.2.6}

A mixture of 2-hydroxybenzonitrile (0.5 mmol), Cs~2~CO~3~ (1.0 mmol), 2.0 mL of DMF, and 2-bromoacetophenone (0.5 mmol) was stirred at room temperature for 10 min in a 5.0 mL microwave vial. After completion of the reaction (monitored by TLC) and formation of **3a**, malononitrile (0.75 mmol) was added. Then, the reaction mixture was kept under microwave heating under sealed and stirring conditions for 30 min, keeping the temperature at 130 °C. After completion of the reaction, the reaction mixture was cooled to room temperature, 10 mL of water was added to the reaction mixture, and then the mixture was extracted with EtOAc (10.0 mL) and further extracted two times with EtOAc (2 × 10 mL). The combined organic phase was dried over Na~2~SO~4~ and concentrated under vacuum. The crude product was purified by column chromatography using hexane/ethyl acetate as the eluent.

#### 2-((3-Aminobenzofuran-2-yl)(phenyl)methylene)malononitrile (**8a**) {#sec4.2.6.1}

Eluent: hexane/ethyl acetate (9:1). Yield: 36 mg (25%); white solid; mp 259--261 °C. IR (ATR) 3449, 3297, 3168, 2921, 2820, 2210, 1735, 1625, 1558, 1496, 1471, 1445, 1414, 1366, 1319, 1297, 1260, 1217, 1187, 1105, 1080, 993 cm^--1^. ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 8.04 (d, *J* = 8.0 Hz, 1H), 7.77 (d, *J* = 8.0 Hz, 2H), 7.70 (d, *J* = 8.0 Hz, 1H), 7.67--7.61 (m, 4H), 7.46 (t, *J* = 8.0 Hz, 1H), 6.90 (bs, 2H) ppm. ^13^C NMR (100 MHz, DMSO-*d*~6~): δ 159.1, 158.4, 145.6, 139.6, 137.6, 131.2, 130.8, 130.1, 129.5, 128.8, 123.9, 122.0, 121.6, 116.8, 112.7, 87.2 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~18~H~12~N~3~O \[M + H\]^+^ 286.0975; found: 286.0978.

#### 2-((3-Aminobenzofuran-2-yl)(3-methoxyphenyl)methylene)malononitrile (**8c**) {#sec4.2.6.2}

Eluent: hexane/ethyl acetate (9:1). Yield: 35 mg (22%); white solid; mp 218--220 °C. IR (ATR) 3454, 3300, 3159, 2921, 2852, 2204, 1738, 1639, 1600, 1559, 1493, 1467, 1450, 1400, 1373, 1264, 1238, 1218, 1153, 1111, 1038, 858 cm^--1^. ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 8.04 (d, *J* = 4.0 Hz, 1H), 7.72 (d, *J* = 8.0 Hz, 1H), 7.65 (t, *J* = 8.0 Hz, 1H), 7.55 (t, *J* = 8.0 Hz, 1H), 7.46 (t, *J* = 8.0 Hz, 1H), 7.33 (s, 2H), 7.18 (d, *J* = 8.0 Hz, 1H), 6.89 (bs, 2H), 3.85 (s, 3H) ppm. ^13^C NMR (100 MHz, DMSO-*d*~6~): δ 159.3, 159.1, 158.4, 145.6, 139.6, 137.4, 132.4, 130.8, 130.1, 123.9, 122.0, 121.7, 121.6, 116.8, 115.5, 115.2, 112.7, 87.3, 55.4 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~19~H~14~N~3~O \[M + H\]^+^ 316.1081; found: 316.1096.

#### 2-Amino-4-phenylbenzofuro\[3,2-*b*\]pyridine-3-carbonitrile (**9a**) {#sec4.2.6.3}

Eluent: hexane/ethyl acetate (7:3). Yield 29 mg (20%); white solid; mp 280--282 °C. IR (ATR) 3336, 3196, 2960, 2918, 2853, 2207, 1651, 1552, 1437, 1409, 1384, 1305, 1274, 1209, 1100, 999 cm^--1^. ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 7.96 (d, *J* = 8.0 Hz, 1H), 7.69--7.64 (m, 3H), 7.62 (dd, *J* = 8.0, 4.0 Hz, 1H), 7.57 (dd, *J* = 8.0, 4.0 Hz, 2H), 7.49 (d, *J* = 8.0 Hz, 1H), 7.31 (t, *J* = 8.0 Hz, 1H), 6.03 (bs, 2H) ppm. ^13^C NMR (100 MHz, DMSO-*d*~6~): δ 155.3, 153.9, 144.1, 132.4, 132.3, 131.3, 130.0, 128.7, 122.9, 122.4, 121.0, 116.6, 116.1, 111.8, 64.7 ppm. HRMS (ESI-TOF): *m*/*z* calcd for C~18~H~12~N~3~O \[M + H\]^+^ 286.0975; found: 286.0979.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b04169](https://pubs.acs.org/doi/10.1021/acsomega.9b04169?goto=supporting-info).Copies of ^1^H and ^13^C NMR spectra for all products, X-ray data for compound **5j** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04169/suppl_file/ao9b04169_si_001.pdf))Crystallographic data of **5j** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04169/suppl_file/ao9b04169_si_002.cif))
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